CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-14 | AKKARAJU SRINIVAS Director | Conversion · Series B Preferred Stock | −1,446,357 | 0 | ||
| 2023-02-14 | Slingsby Brian Taylor Director | Conversion | +4,314,093 | 8,944,579 | ||
| 2023-02-14 | Slingsby Brian Taylor Director | Purchase | +250,000 | $16.00 | $4.0M | 9,194,579 |
| 2023-02-14 | Slingsby Brian Taylor Director | Conversion · Series A Preferred Stock | −2,171,342 | 0 | ||
| 2023-02-14 | Slingsby Brian Taylor Director | Conversion · Series B Preferred Stock | −2,142,751 | 0 | ||
| 2023-02-14 | HBM Healthcare Investments (Cayman) Ltd. 10% owner | Conversion | +1,941,368 | 1,941,368 | ||
| 2023-02-14 | HBM Healthcare Investments (Cayman) Ltd. 10% owner | Conversion | +964,238 | 2,905,606 | ||
| 2023-02-14 | HBM Healthcare Investments (Cayman) Ltd. 10% owner | Purchase | +312,500 | $16.00 | $5.0M | 3,218,106 |
| 2023-02-14 | HBM Healthcare Investments (Cayman) Ltd. 10% owner | Conversion · Series A Preferred Stock | −20,962,895 | 0 | ||
| 2023-02-14 | HBM Healthcare Investments (Cayman) Ltd. 10% owner | Conversion · Series B Preferred Stock | −10,411,846 | 0 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +1,735,629 | 1,735,629 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +131,600 | $16.00 | $2.1M | 1,867,229 |
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +192,847 | 192,847 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,118,400 | $16.00 | $17.9M | 1,311,247 |
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −1,735,629 | 0 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −192,847 | 0 | ||
| 2023-02-09 | Slingsby Brian Taylor Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2023-02-09 | DiRocco Derek Director | Grant or award · Common Stock | +44,000 | 44,000 | ||
| 2023-02-09 | Takahashi Takeshi Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2023-02-09 | Litzka Olivier Director | Grant or award · Stock Option | +44,000 | 44,000 |
Page 22 of 23 · 446 trades